Immune and inflammatory mechanisms in neuropathic pain

G Moalem, DJ Tracey - Brain research reviews, 2006 - Elsevier
Tissue damage, inflammation or injury of the nervous system may result in chronic
neuropathic pain characterised by increased sensitivity to painful stimuli (hyperalgesia), the …

Transdermal and topical drug administration in the treatment of pain

W Leppert, M Malec–Milewska, R Zajaczkowska… - Molecules, 2018 - mdpi.com
The comprehensive treatment of pain is multidimodal, with pharmacotherapy playing a key
role. An effective therapy for pain depends on the intensity and type of pain, the patients' …

Pain and analgesia: The dual effect of nitric oxide in the nociceptive system

Y Cury, G Picolo, VP Gutierrez, SH Ferreira - Nitric oxide, 2011 - Elsevier
Nitric oxide (NO) is involved in many physiological processes and several lines of evidence
have indicated that NO plays a complex and diverse role in the modulation of pain. Nitric …

[PDF][PDF] Discovery of the nitric oxide signaling pathway and targets for drug development

NS Bryan, K Bian, F Murad - Front Biosci, 2009 - article.imrpress.com
Introduction 3. Discovery of NO 3.1. Nitric oxide and the Nobel prize 3.2. NO generation and
nitric oxide synthase 3.2. 1. eNOS 3.2. 2. iNOS 3.2. 3. nNOS 3.3. Nitrovasodilators 4. NO …

[PDF][PDF] Perioperative management of acute pain in the opioid-dependent patient

S Mitra, RS Sinatra, DC Warltier - Anesthesiology, 2004 - Citeseer
PAIN is “an unpleasant sensory and emotional experience associated with actual or
potential tissue damage, or described in terms of such damage.” 1 In settings where pain is …

[HTML][HTML] Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain

BP Roques, MC Fournié-Zaluski, M Wurm - Nature reviews Drug …, 2012 - nature.com
Chronic pain remains unsatisfactorily treated, and few novel painkillers have reached the
market in the past century. Increasing the levels of the main endogenous opioid peptides …

Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase

Z Chen, JS Stamler - Trends in cardiovascular medicine, 2006 - Elsevier
The mitochondrial aldehyde dehydrogenase (ALDH2, mtALDH) was recently found to
catalyze the reduction of nitroglycerin (glyceryl trinitrate [GTN]) to generate nitrite and 1, 2 …

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial

L Chung, L Shapiro, D Fiorentino… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Raynaud's phenomenon (RP) affects 3–9% of the general population and> 90% of
patients with systemic sclerosis. Nitrates are often prescribed for the treatment of RP, but …

Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved?

HL Fung - Annu. Rev. Pharmacol. Toxicol., 2004 - annualreviews.org
Organic nitrates such as nitroglycerin (NTG) have been used as potent vasodilators in
medicine for more than a century, but their biochemical mechanisms of action, particularly in …

Modulation of opioid actions by nitric oxide signaling.

N Toda, S Kishioka, Y Hatano, H Toda - Anesthesiology, 2009 - europepmc.org
Nitric oxide (NO) plays pivotal roles in controlling physiological functions, participates in
pathophysiological intervention, and is involved in mechanisms underlying beneficial or …